Akebia Therapeutics (DE:AX9)
FRANKFURT:AX9
Holding DE:AX9?
Track your performance easily

Akebia Therapeutics (AX9) Financial Statements

2 Followers

Akebia Therapeutics Financial Overview

Akebia Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Akebia Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is €-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 43.65M$ 32.61M$ 56.07M$ 42.05M$ 42.24M
Gross Profit$ 35.61M$ 21.00M$ 36.70M$ 24.04M$ 48.10M
EBIT$ -8.58M$ -17.27M$ -4.81M$ -12.76M$ -9.27M
EBITDA$ 818.00K$ -7.91M$ 2.40M$ -3.37M$ 123.00K
Net Income Common Stockholders$ -8.58M$ -17.98M$ -47.00K$ -14.49M$ -11.17M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 39.50M$ 41.96M$ 42.92M$ 46.53M$ 53.57M
Total Assets$ 220.20M$ 225.48M$ 241.70M$ 235.00M$ 253.67M
Total Debt$ 44.33M$ 37.78M$ 43.63M$ 52.84M$ 53.97M
Net Debt$ 4.83M$ -4.18M$ 705.00K$ 6.31M$ 394.00K
Total Liabilities$ 253.95M$ 252.74M$ 272.29M$ 274.42M$ 280.52M
Stockholders Equity$ -33.75M$ -27.26M$ -30.58M$ -39.42M$ -26.81M
Cash Flow-
Free Cash Flow$ -10.10M$ -19.43M$ -2.31M$ -7.13M$ 3.64M
Operating Cash Flow$ -10.07M$ -19.43M$ -2.31M$ -7.13M$ 3.64M
Investing Cash Flow$ -29.00K----
Financing Cash Flow$ 7.64M$ 18.48M$ -1.29M$ 50.00K$ -8.00M
Currency in USD

Akebia Therapeutics Earnings and Revenue History

Akebia Therapeutics Debt to Assets

Akebia Therapeutics Cash Flow

Akebia Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis